No Data
CASI Pharmaceuticals Sees Dramatic After-Hours Surge
CASI Pharmaceuticals, Inc. (NASDAQ: CASI) had an uneventful trading session on Wednesday, with the stock dipping slightly by 1.2%. However, after the close of regular trading hours, the stock saw a significant after-hours surge, climbing by as much as 65%. The volume was about three times higher than the average, indicating strong buying interest among ...
Stocks to Watch: Levi Strauss, Casi Pharmaceuticals, Recursion Pharmaceuticals, Aterian
By Sabela Ojea Levi Strauss reported lower-than-expected revenue in its fiscal second quarter and left its outlook for the year unchanged. Shares of the jeans maker fall 12%, to $20.28, in after-hour
CASI Pharmaceuticals' Shares Rally Following CEO's Offer to Buy China Operations
CASI Pharmaceuticals' shares soared post-market on Wednesday after the company said it's considering a $40 million offer to sell its business operations in China to board chairman and chief executive officer Dr. Wei-Wu He.
CASI Pharmaceuticals: Committee to Evaluate Other Strategic, Business Alternatives Available in Respect to Business Ops in China >CASI
CASI Pharmaceuticals: Committee to Evaluate Other Strategic, Business Alternatives Available in Respect to Business Ops in China >CASI
CASI Pharmaceuticals: Board Has Formed Special Committee of Incumbent Independent Directors to Evaluate Transaction Contemplated >CASI
CASI Pharmaceuticals: Board Has Formed Special Committee of Incumbent Independent Directors to Evaluate Transaction Contemplated >CASI
Express News | CASI Pharmaceuticals Inc - Proposed Deal for Purchase Price of $40.0 Mln, Which Shall Include Assumption of up to $20.0 Mln of Indebtedness of Company